Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 5.22M
2: EX-4.29 Instrument Defining the Rights of Security Holders HTML 57K
3: EX-10.22 Material Contract HTML 238K
4: EX-10.45 Material Contract HTML 72K
5: EX-10.47 Material Contract HTML 62K
6: EX-10.53 Material Contract HTML 99K
7: EX-10.54 Material Contract HTML 118K
8: EX-21.1 Subsidiaries List HTML 182K
9: EX-23.1 Consent of Expert or Counsel HTML 43K
14: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 52K
Awarded Compensation
10: EX-31.1 Certification -- §302 - SOA'02 HTML 47K
11: EX-31.2 Certification -- §302 - SOA'02 HTML 47K
12: EX-32.1 Certification -- §906 - SOA'02 HTML 44K
13: EX-32.2 Certification -- §906 - SOA'02 HTML 44K
20: R1 Cover Page HTML 109K
21: R2 Audit Information HTML 48K
22: R3 Consolidated Statements of Operations HTML 162K
23: R4 Consolidated Statements of Comprehensive Income HTML 86K
24: R5 Consolidated Balance Sheets HTML 198K
25: R6 Consolidated Balance Sheets (Parenthetical) HTML 65K
26: R7 Consolidated Statements of Cash Flows HTML 163K
27: R8 Consolidated Statements of Cash Flows HTML 44K
(Parenthetical)
28: R9 Consolidated Statements of Shareholders' Equity HTML 128K
29: R10 Consolidated Statements of Shareholders' Equity HTML 49K
(Parentheticals)
30: R11 Significant Accounting Policies HTML 427K
31: R12 Acquisitions, Divestitures and Asset Sales HTML 114K
32: R13 Restructuring Program HTML 51K
33: R14 Investments HTML 342K
34: R15 Fair Value HTML 236K
35: R16 Goodwill and Other Intangibles HTML 103K
36: R17 Leases HTML 192K
37: R18 Health Care Costs Payable HTML 95K
38: R19 Other Insurance Liabilities and Separate Accounts HTML 176K
39: R20 Borrowings and Credit Agreements HTML 128K
40: R21 Pension Plans and Other Postretirement Benefits HTML 206K
41: R22 Income Taxes HTML 111K
42: R23 Stock Incentive Plans HTML 123K
43: R24 Shareholders' Equity HTML 71K
44: R25 Other Comprehensive Income (Loss) HTML 102K
45: R26 Earnings Per Share HTML 62K
46: R27 Reinsurance HTML 75K
47: R28 Commitments and Contingencies HTML 96K
48: R29 Segment Reporting HTML 200K
49: R30 Pay vs Performance Disclosure HTML 55K
50: R31 Insider Trading Arrangements HTML 49K
51: R32 Significant Accounting Policies (Policies) HTML 261K
52: R33 Significant Accounting Policies (Tables) HTML 310K
53: R34 Acquisitions, Divestitures and Asset Sales HTML 105K
(Tables)
54: R35 Restructuring Program (Tables) HTML 48K
55: R36 Investments (Tables) HTML 350K
56: R37 Fair Value (Tables) HTML 245K
57: R38 Goodwill and Other Intangibles (Tables) HTML 105K
58: R39 Leases (Tables) HTML 134K
59: R40 Health Care Costs Payable (Tables) HTML 97K
60: R41 Other Insurance Liabilities and Separate Accounts HTML 207K
(Tables)
61: R42 Borrowings and Credit Agreements (Tables) HTML 120K
62: R43 Pension Plans and Other Postretirement Benefits HTML 222K
(Tables)
63: R44 Income Taxes (Tables) HTML 112K
64: R45 Stock Incentive Plans (Tables) HTML 124K
65: R46 Shareholders' Equity (Tables) HTML 64K
66: R47 Other Comprehensive Income (Loss) (Tables) HTML 102K
67: R48 Earnings Per Share (Tables) HTML 61K
68: R49 Reinsurance (Tables) HTML 74K
69: R50 Segment Reporting (Tables) HTML 195K
70: R51 Significant Accounting Policies - Narrative HTML 173K
(Details)
71: R52 Significant Accounting Policies - Cash and Cash HTML 54K
Equivalents, Restricted Cash and Cash Equivalents
(Details)
72: R53 Significant Accounting Policies - Accounts HTML 61K
Receivable (Details)
73: R54 Significant Accounting Policies - Deferred HTML 53K
Acquisition Costs (Details)
74: R55 Significant Accounting Policies - Property and HTML 66K
Equipment (Details)
75: R56 Significant Accounting Policies - Disaggregation HTML 114K
of Revenue (Details)
76: R57 Significant Accounting Policies - Receivables and HTML 48K
Contract Balances (Details)
77: R58 Significant Accounting Policies - Contract HTML 53K
Balances (Details)
78: R59 Significant Accounting Policies - Variable HTML 88K
Interest Entities (Details)
79: R60 Significant Accounting Policies - New Accounting HTML 83K
Pronouncements Recently Adopted (Details)
80: R61 Significant Accounting Policies - Changes in HTML 84K
Balances of Long-duration Insurance Liabilities
(Details)
81: R62 Significant Accounting Policies - Adjustments HTML 231K
Resulting From Applying New Accounting Standard
(Details)
82: R63 Acquisitions, Divestitures and Asset Sales - HTML 125K
Narrative (Details)
83: R64 Acquisitions, Divestitures and Asset Sales - HTML 66K
Schedule of Fair Value of Consideration
Transferred (Details)
84: R65 Acquisitions, Divestitures and Asset Sales - HTML 105K
Schedule of Estimated Fair Values of Assets
Acquired and Liabilities Assumed (Details)
85: R66 Acquisitions, Divestitures and Asset Sales - HTML 67K
Summary of the Valuation of Goodwill Allocated to
Business Segments (Details)
86: R67 Acquisitions, Divestitures and Asset Sales - HTML 64K
Summary of Fair Values and Weighted Average Useful
Lives for Intangible Assets Acquired (Details)
87: R68 Restructuring Program - Narrative (Details) HTML 51K
88: R69 Restructuring Program - Change in Severance and HTML 49K
Employee-related Restructuring Charge Liability
(Details)
89: R70 Investments - Total Investments Schedule (Details) HTML 62K
90: R71 Investments - Narrative (Details) HTML 57K
91: R72 Investments - Debt Securities (Details) HTML 96K
92: R73 Investments - Debt Securities by Maturity HTML 86K
(Details)
93: R74 Investments - Unrealized Loss Position (Details) HTML 119K
94: R75 Investments - Unrealized Loss Position Maturities HTML 106K
(Details)
95: R76 Investments - Mortgage Loans (Details) HTML 50K
96: R77 Investments - Mortgage Loans Credit Ratings HTML 92K
Indicator (Details)
97: R78 Investments - Mortgage Loan Principal Repayments HTML 56K
(Details)
98: R79 Investments - Net Investment Income (Details) HTML 67K
99: R80 Investments - Realized Gains (Details) HTML 50K
100: R81 Fair Value - Measurement on a Recurring Basis HTML 125K
(Details)
101: R82 Fair Value - Changes in Level 3 Financial Assets HTML 95K
(Details)
102: R83 Fair Value - Narrative (Details) HTML 56K
103: R84 Fair Value - Gross Transfers Into (Out of) Level 3 HTML 54K
(Details)
104: R85 Fair Value - Carrying Value and Fair Value HTML 74K
Classified by Level (Details)
105: R86 Fair Value - Separate Accounts Fair Value HTML 81K
(Details)
106: R87 Goodwill and Other Intangibles - Goodwill HTML 68K
(Details)
107: R88 Goodwill and Other Intangibles - Narrative HTML 61K
(Details)
108: R89 Goodwill and Other Intangibles - Intangible Assets HTML 79K
(Details)
109: R90 Goodwill and Other Intangibles - Future HTML 54K
Amortization Expense (Details)
110: R91 Leases - Narrative (Details) HTML 80K
111: R92 Leases - Summary of the Components of Net Lease HTML 62K
Cost (Details)
112: R93 Leases - Supplemental Cash Flow Information HTML 58K
(Details)
113: R94 Leases - Supplemental Balance Sheet Information HTML 89K
(Details)
114: R95 Leases - Maturities of Operating and Finance Lease HTML 104K
Liabilities (Details)
115: R96 Health Care Costs Payable - Incurred and Paid HTML 59K
Health Care Claims Development (Details)
116: R97 Health Care Costs Payable - Narrative (Details) HTML 49K
117: R98 Health Care Costs Payable - Liability for Unpaid HTML 59K
Claims and Claims Adjustment Expense (Details)
118: R99 Health Care Costs Payable - Components of Change HTML 96K
in Health Care Costs Payable (Details)
119: R100 Other Insurance Liabilities and Separate Accounts HTML 122K
- Changes in Liability for Future Policy Benefits
(Details)
120: R101 Other Insurance Liabilities and Separate Accounts HTML 52K
- Undiscounted Expected Gross Premiums and
Expected Future Benefit Payments (Details)
121: R102 Other Insurance Liabilities and Separate Accounts HTML 55K
- Weighted-average Interest Rates and Durations
(Details)
122: R103 Other Insurance Liabilities and Separate Accounts HTML 67K
- Roll Forward of Policyholders' Funds (Details)
123: R104 Other Insurance Liabilities and Separate Accounts HTML 81K
- Separate Account Assets (Details)
124: R105 Other Insurance Liabilities and Separate Accounts HTML 63K
- Roll Forward of Separate Accounts (Details)
125: R106 Borrowings and Credit Agreements - Schedule of HTML 201K
Borrowings (Details)
126: R107 Borrowings and Credit Agreements - Debt Maturities HTML 69K
(Details)
127: R108 Borrowings and Credit Agreements - Short-term HTML 87K
Borrowings (Details)
128: R109 Borrowings and Credit Agreements - Long-term HTML 151K
Borrowings (Details)
129: R110 Pension Plans and Other Postretirement Benefits - HTML 74K
Narrative (Details)
130: R111 Pension Plans and Other Postretirement Benefits - HTML 92K
Benefit Obligations and Plan Assets (Details)
131: R112 Pension Plans and Other Postretirement Benefits - HTML 59K
Net Periodic Benefit Cost (Income) (Details)
132: R113 Pension Plans and Other Postretirement Benefits - HTML 52K
Weighted Average Assumptions Used (Details)
133: R114 Pension Plans and Other Postretirement Benefits - HTML 172K
Fair Value of Pension Plan Assets (Details)
134: R115 Pension Plans and Other Postretirement Benefits - HTML 60K
Changes in Level 3 Pension Plan Assets (Details)
135: R116 Pension Plans and Other Postretirement Benefits - HTML 60K
Defined Benefit Plans Expected Benefit (Details)
136: R117 Income Taxes - Income Tax Provision (Details) HTML 66K
137: R118 Income Taxes - Effective Tax Rate Reconciliation HTML 60K
(Details)
138: R119 Income Taxes - Deferred Tax Assets and Liabilities HTML 84K
(Details)
139: R120 Income Taxes - Narrative (Details) HTML 53K
140: R121 Income Taxes - Unrecognized Tax Benefits (Details) HTML 57K
141: R122 Stock Incentive Plans - Narrative (Details) HTML 115K
142: R123 Stock Incentive Plans - Stock-Based Compensation HTML 56K
Expense (Details)
143: R124 Stock Incentive Plans - Restricted Stock Unit and HTML 75K
Performance Stock Unit Activity (Details)
144: R125 Stock Incentive Plans - Stock Option and SAR HTML 123K
Activity (Details)
145: R126 Stock Incentive Plans - Valuation Assumptions HTML 69K
(Details)
146: R127 Shareholders' Equity - Share Repurchases (Details) HTML 61K
147: R128 Shareholders' Equity - Accelerated Share HTML 78K
Repurchases (Details)
148: R129 Shareholders' Equity - Dividends (Details) HTML 50K
149: R130 Shareholders' Equity - Regulatory Requirements HTML 58K
(Details)
150: R131 Shareholders' Equity - Noncontrolling Interests HTML 48K
(Details)
151: R132 Other Comprehensive Income (Loss) (Details) HTML 121K
152: R133 Earnings Per Share (Details) HTML 86K
153: R134 Reinsurance - Narrative (Details) HTML 47K
154: R135 Reinsurance - Reinsurance Recoverables (Details) HTML 59K
155: R136 Reinsurance - Effects of Reinsurance (Details) HTML 65K
156: R137 Commitments and Contingencies (Details) HTML 77K
157: R138 Segment Reporting - Narrative (Details) HTML 54K
158: R139 Segment Reporting - Retrospective Adjustments to HTML 89K
Segment Composition (Details)
159: R140 Segment Reporting - Reconciliation of Financial HTML 92K
Measures of Segments to Consolidated Totals
(Details)
160: R141 Segment Reporting - Reconciliation from Operating HTML 74K
Income to Adjusted Operating Income (Details)
161: R9999 Uncategorized Items - cvs-20231231.htm HTML 62K
163: XML IDEA XML File -- Filing Summary XML 302K
166: XML XBRL Instance -- cvs-20231231_htm XML 8.02M
162: EXCEL IDEA Workbook of Financial Report Info XLSX 424K
16: EX-101.CAL XBRL Calculations -- cvs-20231231_cal XML 590K
17: EX-101.DEF XBRL Definitions -- cvs-20231231_def XML 2.00M
18: EX-101.LAB XBRL Labels -- cvs-20231231_lab XML 4.37M
19: EX-101.PRE XBRL Presentations -- cvs-20231231_pre XML 2.86M
15: EX-101.SCH XBRL Schema -- cvs-20231231 XSD 426K
164: JSON XBRL Instance as JSON Data -- MetaLinks 1,093± 1.70M
165: ZIP XBRL Zipped Folder -- 0000064803-24-000007-xbrl Zip 1.37M
I, Karen S. Lynch, President and Chief Executive Officer of CVS Health Corporation, certify that:
1. I have reviewed this annual report on Form 10-K of CVS Health Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.